You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Disseminating tumor cells,breast cancer,docetaxel,adjuvant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Oslo (Docetaxel)

Completed
  • Breast Cancer
  • Oslo, Norway
    RRHF
Apr 21, 2022

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Circulating Tumor Cell Phenotype Surveillance in Breast Cancer

Recruiting
  • Breast Neoplasms
  • +2 more
  • CTC detection
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Apr 5, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Breast Tumor, Neoplastic Cells, Circulating Trial in Handan (Peripheral blood sampling for circulating tumor cells)

Active, not recruiting
  • Breast Neoplasm
  • Neoplastic Cells, Circulating
  • Peripheral blood sampling for circulating tumor cells
  • Handan, Hebei, China
    Kunwu Yan
Jan 26, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Method(s)1 Attribution
  • Method(s)2 Attribution,
  • Colorado Springs, Colorado
    PNAF Medical
Nov 23, 2023

HER2-positive Advanced Breast Cancer Patients Treated With ADC

Recruiting
  • Breast Cancer
  • HER2 expression of circulating tumor cells
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Apr 18, 2023

HER2-low Advanced Breast Cancer Patients Treated With ADC

Recruiting
  • Breast Cancer
  • HER2 expression of circulating tumor cells
  • Beijing, Beijing, China
    The Fifth Medical Center of PLA General Hospital
Apr 18, 2023

Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

Terminated
Has Results
  • Breast Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 31, 2022

Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant

Not yet recruiting
  • Breast Cancer
  • +5 more
  • Breast Surgery (BCS or mastectomy) with TAD/SNB
  • Adjuvant Radiation Therapy
  • (no location specified)
Oct 24, 2023

Breast Tumors Trial in Beijing (Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy

Recruiting
  • Breast Neoplasms
  • Preoperative MRI-guided tumor-bed boost and postopreative ultra-hypofractionated radiotherapy (26 Gy/5.2Gy/5)
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Nov 1, 2022

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)

Recruiting
  • Metastatic Breast Cancer
  • CellSearch Circulating Tumor Cells
  • Rochester, Minnesota
  • +1 more
Dec 21, 2022

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

Recurrence Score on Adjuvant Treatment Decisions in Breast

Recruiting
  • Breast Cancer Female
    • Tübingen, BW, Germany
      Department for Women's Health
    Nov 4, 2022

    Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      Cancer Hospital, ChineseAMS
    Mar 17, 2022

    HER2-positive Breast Cancer, Adjuvant Therapy Trial in Hangzhou (Paclitaxel, Trastuzumab, Docetaxel)

    Recruiting
    • HER2-positive Breast Cancer
    • Adjuvant Therapy
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 26, 2021

    Breast Cancer, Circulating Tumor Cell Trial (GILUPI CellCollector®)

    Recruiting
    • Breast Cancer
    • Circulating Tumor Cell
    • GILUPI CellCollector®
    • Shanghai, Shanghai, China
      Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
    Oct 3, 2022

    Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

    Completed
    • Breast Cancer
    • Amsterdam, Netherlands
      Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
    Nov 16, 2022

    Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

    Recruiting
    • Prevention of Chemotherapy-induced Myelosuppression
    • ALRN-6924
    • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
    • Tamarac, Florida
    • +14 more
    Jan 31, 2023

    Breast Cancer, Chemotherapeutic Toxicity Trial in Hanzhou (Liposomal doxorubicin + Cyclophosphamide vs Docetaxel +

    Recruiting
    • Breast Cancer
    • Chemotherapeutic Toxicity
    • Liposomal doxorubicin + Cyclophosphamide vs Docetaxel + Cyclophosphamide
    • Hanzhou, Zhejing, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Apr 7, 2022

    Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer

    Recruiting
    • Breast Neoplasms
    • Peripheral blood draw
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 9, 2022